Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PIRS save search
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
Published: 2023-07-18 (Crawled : 13:20) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 33.55%
H: 47.44%
C: -16.28%
update pharmaceuticals
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
Published: 2021-05-25 (Crawled : 13:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 21.62%
H: 68.44%
C: 67.11%
collaboration respiratory
Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis
Published: 2021-06-25 (Crawled : 12:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 12.13%
H: 0.2%
C: -18.37%
covid fibrosis
Pieris Announces Amendment of Existing Immuno-oncology Multi-target Collaboration with Seagen
Published: 2021-03-25 (Crawled : 13:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 11.2%
H: 0.0%
C: -7.19%
collaboration
Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 13:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 10.01%
H: 5.32%
C: 4.43%
prs-343 presentation positive pharmaceuticals meeting
Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 5.97%
H: 0.56%
C: -2.66%
financial results results
Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer
Published: 2021-06-24 (Crawled : 12:15) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 5.65%
H: 22.19%
C: 16.84%
treatment cancer drug designation
Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
Published: 2023-08-17 (Crawled : 13:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 5.11%
H: 10.24%
C: 2.81%
bos-342 pharmaceuticals milestone study
Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of CD228 x 4-1BB Bispecific Molecule (Mabcalin SGN-BB228 (PRS-346)
Published: 2023-01-10 (Crawled : 14:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 4.69%
H: 5.97%
C: 5.22%
cd228 pharmaceuticals trial milestone
Pieris Pharmaceuticals To Present at H.C. Wainwright Global Investment Conference
Published: 2022-05-18 (Crawled : 12:20) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 3.51%
H: 2.26%
C: -1.69%
conference
Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS
Published: 2022-08-24 (Crawled : 13:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 3.33%
H: 3.23%
C: 1.94%
prs-400 preclinical presentation
BioSpace Movers & Shakers, Aug. 27
Published: 2021-08-27 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
VXRT | News | $0.7208 -3.3% 770K
|
Health Technology
|
| O: 0.33%
H: 1.78%
C: 0.11%
VNDA | $4.63 720K
|
Health Technology
|
| O: 0.54%
H: 3.83%
C: 3.35%
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 0.22%
H: 4.03%
C: 2.68%
GH | News 4 | $17.84 2.88% 730K
|
Health Services
|
| O: 0.43%
H: 2.75%
C: 1.7%
GNCA | $0.051
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -4.3%
ACAD | News | $16.66 -0.48% 310K
|
Health Technology
|
| O: 0.0%
H: 4.2%
C: 2.58%
IBIO | $1.87 -1.58% 86K
|
Health Technology
|
| O: 1.64%
H: 4.03%
C: 2.42%
space spac
Pieris Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 1.6%
H: 6.81%
C: 0.52%
financial results results
Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2a Trial of PRS-060/AZD1402
Published: 2022-01-03 (Crawled : 12:30) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 1.59%
H: 3.52%
C: 1.82%
prs-060 phase 2 als trial milestone phase 2b
Pieris Pharmaceuticals to Host Full-Year 2020 Investor Call and Provide Corporate Update on March 30, 2021
Published: 2021-03-23 (Crawled : 13:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 1.42%
H: 1.05%
C: -8.74%
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 1.42%
H: 2.38%
C: 1.96%
Abcuro Appoints Darlene Deptula-Hicks to its Board of Directors
Published: 2021-10-19 (Crawled : 12:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 2.13%
H: 9.47%
C: 2.73%
TTOO A | $2.62 -3.68% 180K
|
Health Technology
|
| O: -0.52%
H: 3.92%
C: 3.21%
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 1.37%
H: 1.8%
C: -0.68%
Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference
Published: 2023-05-22 (Crawled : 14:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 1.34%
H: 4.59%
C: 4.59%
prs-400 conference presentation international pharmaceuticals preclinical
Pieris Pharmaceuticals To Host Full-Year 2021 Investor Call and Provide Corporate Update on March 1, 2022
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 1.32%
H: 5.21%
C: -1.95%
als
Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member
Published: 2021-08-23 (Crawled : 00:00) - biospace.com/
PIRS | $11.6 -0.75% 33K
|
Health Technology
|
| O: 0.0%
H: 7.43%
C: 6.93%
GH | News 4 | $17.84 2.88% 730K
|
Health Services
|
| O: 1.19%
H: 5.11%
C: 4.88%
biopharma
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
RBBN 4 | $3.29 28.02% 2.2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.